About Us

About Us

The Singapore Translational Cancer Consortium (STCC) was established in 2020 as a nationally coordinated initiative and network to synergize cancer research and translational capabilities across Singapore.

Latest News

Collaborate with Us

We partner with key stakeholders and institutions to implement joint platforms that are functionally integrated and operational in support of the nation’s long term goals to achieve value-based healthcare and economic outcomes through deeper industry collaborations, patents and invention disclosures, start-ups and clinically validated diagnostics.

Supported by

Our Partners